Concord Drugs Limited (BOM:538965)
67.93
-2.07 (-2.96%)
At close: Jul 27, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 907.63 million as of July 28, 2026. Its market cap has increased by 58.59% in one year.
Market Cap
907.63M
Enterprise Value
780.95M
Revenue
787.37M
Ranking
n/a
PE Ratio
72.52
Stock Price
67.93
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 907.63M, an increase of 526.80%. That is a compound annual growth rate of 17.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 894.98M | -17.64% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bal Pharma | 1.39B |
| Lactose (India) | 1.26B |
| Aayush Wellness | 1.14B |
| Pharmaids Pharmaceuticals | 1.08B |
| Mercury Laboratories | 1.00B |
| Denis Chem Lab | 968.45M |
| Godavari Drugs | 891.61M |
| Makers Laboratories | 883.29M |